Simplex Trading
JUNO

Simplex Trading’s Juno Therapeutics, Inc. JUNO Stock Holding History

Simplex Trading’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-953
Closed -$666K – 7446
2017
Q4 		$666K Buy
953
+360
+61% +$18K 0.03% 568
2017
Q3 		$562K Buy
593
+68
+13% +$2.32K 0.02% 610
2017
Q2 		$277K Sell
525
-122
-19% -$3.01K 0.01% 998
2017
Q1 		$85K Sell
647
-264
-29% -$5.66K ﹤0.01% 1897
2016
Q4 		$61K Buy
911
+242
+36% +$5.92K ﹤0.01% 1974
2016
Q3 		$35K Buy
669
+138
+26% +$4.29K ﹤0.01% 2439
2016
Q2 		$98K Buy
531
+189
+55% +$7.84K 0.01% 1489
2016
Q1 		$128K Buy
342
+67
+24% +$2.33K 0.01% 1166
2015
Q4 		$103K Sell
275
-300
-52% -$14.9K 0.01% 1336
2015
Q3 		$183K Buy
575
+193
+51% +$8.46K 0.01% 975
2015
Q2 		$188K Buy
382
+265
+226% +$14.1K 0.02% 826
2015
Q1 		$166K Buy
+117
New +$5.68K 0.02% 807

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Simplex Trading's JUNO Position: Q1 2018 in Review

Simplex Trading sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 16,285 shares — an estimated $744K sold.

Simplex Trading first reported a position in JUNO in Q2 2015 and held it in 7 quarters. The position peaked at $1.19M in Q2 2016. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Simplex Trading reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Simplex Trading sold 16,285 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $744K.
  • Simplex Trading first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 7 quarters.
  • Simplex Trading's Juno Therapeutics, Inc. position peaked at $1.19M in Q2 2016.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Simplex Trading's 13F filing for Q1 2018, filed 26 Apr 2018.